Masimo (MASI) Total Current Liabilities (2010 - 2026)
Masimo's (MASI) quarterly Total Current Liabilities came in at $325.4 million in Q2 2026, down 40.46% year-on-year from $546.5 million in Q2 2025, and down 12.43% quarter-over-quarter from $371.6 million in Q1 2026.
Masimo (MASI) Total Current Liabilities (2010 - 2026) Analysis & Trends
Masimo's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $325.4 million for Q2 2026.
- On a quarterly basis, Total Current Liabilities fell 40.46% year-over-year to $325.4 million in Q2 2026; TTM through Apr 2026 was $325.4 million, a 40.46% decrease from a year earlier, with the FY2026 full-year figure at $371.6 million, down 39.84% from the prior year.
- Total Current Liabilities slipped to $325.4 million in Q2 2026 per MASI's latest filing, from $371.6 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $637.6 million in Q3 2024 and bottomed at $254.3 million in Q2 2022.
- The 5-year median for Total Current Liabilities is $557.9 million (2022), against an average of $505.6 million.
- Across the five-year window, Total Current Liabilities jumped 157.3% in 2022 and tumbled 42.02% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $630.0 million in 2022, then retreated by 10.51% to $563.8 million in 2023, then rose by 9.56% to $617.7 million in 2024, then plunged by 40.15% to $369.7 million in 2025, then slipped by 11.98% to $325.4 million in 2026.
- Per Business Quant, the three latest MASI Total Current Liabilities figures stand at $325.4 million (Q2 2026), $371.6 million (Q1 2026), and $369.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 325.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 325.40 Mn |
| Jan 3, 2026 | 371.60 Mn |
| Sep 27, 2025 | 369.70 Mn |
| Jun 28, 2025 | 592.10 Mn |
| Mar 29, 2025 | 546.50 Mn |
| Dec 28, 2024 | 617.70 Mn |
| Sep 28, 2024 | 637.60 Mn |
| Jun 29, 2024 | 546.20 Mn |
| Mar 30, 2024 | 504.20 Mn |
| Dec 30, 2023 | 563.80 Mn |
| Sep 30, 2023 | 578.80 Mn |
| Jul 1, 2023 | 571.90 Mn |
| Apr 1, 2023 | 583.20 Mn |
| Dec 31, 2022 | 630.00 Mn |
| Oct 1, 2022 | 587.30 Mn |
| Jul 2, 2022 | 552.00 Mn |
| Apr 2, 2022 | 254.31 Mn |
| Jan 1, 2022 | 267.70 Mn |
| Oct 2, 2021 | 228.25 Mn |
| Jul 3, 2021 | 220.03 Mn |